EASI, Other Instruments Recommended to Evaluate Patients With Atopic Dermatitis.

Clinicians should use one of three validated instruments to measure signs of atopic dermatitis (AD) in their clinical practice, according to a consensus statement published in JAMA Dermatology. The recommended instruments are the Eczema Area and Severity Index (EASI), the Validated Investigator Global Assessment for AD (vIGAAD), and the Investigator's Global Assessment (IGA) combined with a body surface area (BSA) assessment. The statement was based on a systematic review conducted by the Harmonizing Outcome Measures for Eczema Clinical Practice initiative. The authors acknowledged that the EASI may be challenging to use, but studies have shown that completion times can be as low as two minutes with trained investigators. [Extracted from the article]